FDA 510(k) SOP + Substantial Equivalence Matrix — 21 CFR & QMSR (USA)
€69.0021 CFR · 510(k), De Novo, PMA · eSTAR FDA Marketing Authorization Procedure and Substantial Equivalence Matrix — USA A procedure for the US pathways from classification to registration and listing, and an Excel workbook with the pathway decision, a substantial equivalence matrix and a submission readiness checklist. €69 VAT calculated at checkout Get the…
